Dupixent (dupilumab) has been a breakthrough treatment for people with severe eczema, asthma, and other inflammatory conditions. For many, it has provided relief when other therapies failed. However, ...
If you or someone you love uses Dupixent, you may have recently seen television ads or online headlines linking the medication to rare forms of cancer. For many patients, this has caused confusion, ...
The approval in adolescent patients was based on evidence from the phase 3 SINUS-24 and SINUS-52 trials. The Food and Drug Administration (FDA) has expanded the approval of Dupixent ® (dupilumab) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results